Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oriano Mecarelli

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Neuroscience Letters|March 22, 2008
Analysis of LGI1 promoter sequence, PDYN and GABBR1 polymorphisms in sporadic and familial lateral temporal lobe epilepsyGiorgia Bovo, Erica Diani, Francesca Bisulli, et al.
Epilepsy & Behavior : E&B|December 16, 2014
An educational campaign about epilepsy among Italian primary school teachers. 2. The results of a focused training programOriano Mecarelli, Paolo Messina, Giuseppe Capovilla, et al.
Epilepsia Open|June 5, 2025
Real-world use of adjunctive perampanel for focal-onset seizures in Italy: A mirroring clinical practice study of perampanel in adults and adolescents (AMPA)Alfredo D'Aniello, Anna Teresa Giallonardo, Paolo Tinuper, et al.
Neurology and Therapy|September 15, 2022
Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World StudySimona Lattanzi, Laura Canafoglia, Maria Paola Canevini, et al.
CNS Drugs|September 3, 2021
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)Simona Lattanzi, Laura Canafoglia, Maria Paola Canevini, et al.
Neurology and Therapy|March 12, 2025
Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk StudySimona Lattanzi, Laura Canafoglia, Maria Paola Canevini, et al.
Drugs & Aging|March 28, 2022
Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)Simona Lattanzi, Laura Canafoglia, Maria Paola Canevini, et al.
Epilepsia|December 11, 2023
Adjunctive brivaracetam and sustained seizure frequency reduction in very active focal epilepsySimona Lattanzi, Laura Canafoglia, Maria Paola Canevini, et al.
Seizure|March 23, 2022
Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST)Simona Lattanzi, Laura Canafoglia, Maria Paola Canevini, et al.
American Journal of Human Genetics|April 14, 2015
Mutations in the GABA Transporter SLC6A1 Cause Epilepsy with Myoclonic-Atonic SeizuresGemma L Carvill, Jacinta M McMahon, Amy Schneider, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Neuroscience Letters|March 22, 2008
Analysis of LGI1 promoter sequence, PDYN and GABBR1 polymorphisms in sporadic and familial lateral temporal lobe epilepsyGiorgia Bovo, Erica Diani, Francesca Bisulli, et al.
Epilepsy & Behavior : E&B|December 16, 2014
An educational campaign about epilepsy among Italian primary school teachers. 2. The results of a focused training programOriano Mecarelli, Paolo Messina, Giuseppe Capovilla, et al.
Epilepsia Open|June 5, 2025
Real-world use of adjunctive perampanel for focal-onset seizures in Italy: A mirroring clinical practice study of perampanel in adults and adolescents (AMPA)Alfredo D'Aniello, Anna Teresa Giallonardo, Paolo Tinuper, et al.
Neurology and Therapy|September 15, 2022
Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World StudySimona Lattanzi, Laura Canafoglia, Maria Paola Canevini, et al.
CNS Drugs|September 3, 2021
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)Simona Lattanzi, Laura Canafoglia, Maria Paola Canevini, et al.
Neurology and Therapy|March 12, 2025
Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk StudySimona Lattanzi, Laura Canafoglia, Maria Paola Canevini, et al.
Drugs & Aging|March 28, 2022
Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)Simona Lattanzi, Laura Canafoglia, Maria Paola Canevini, et al.
Epilepsia|December 11, 2023
Adjunctive brivaracetam and sustained seizure frequency reduction in very active focal epilepsySimona Lattanzi, Laura Canafoglia, Maria Paola Canevini, et al.
Seizure|March 23, 2022
Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST)Simona Lattanzi, Laura Canafoglia, Maria Paola Canevini, et al.
American Journal of Human Genetics|April 14, 2015
Mutations in the GABA Transporter SLC6A1 Cause Epilepsy with Myoclonic-Atonic SeizuresGemma L Carvill, Jacinta M McMahon, Amy Schneider, et al.
Pageof 8